Clinical Trials Directory

Trials / Completed

CompletedNCT00817245

Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR)

Effect of Helicobacter Pylori Treatment on Remission of Idiopathic Central Serous Chorioretinopathy (ICSCR)

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Tabriz University · Academic / Other
Sex
All
Age
28 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Etiology of ICSCR is not known however recent studies regard the role of immunologic and infectious processes in the pathogenesis of ICSCR.one of these hypothesis is the role of helicobacter pylori in the pathogenesis of ICSCR so perhaps treatment of h pylori have positive effect on the remission of ICSCR.

Detailed description

we will choose 50 cases of patients with ICSCR who are infected with h.pylori.25 cases will receive anti h.pylori regiment and 25 cases as controls will receive no medication.then we will compare the time of submacular fluid resorption and macular thickness and visual acuity among these two groups.

Conditions

Interventions

TypeNameDescription
DRUGomeprazole, Amoxicillin, metronidazolewe will evaluate the effect of medication(anti h.pylori) on the remission of ICSCR

Timeline

Start date
2008-03-01
Primary completion
2008-10-01
Completion
2009-01-01
First posted
2009-01-06
Last updated
2009-01-06

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT00817245. Inclusion in this directory is not an endorsement.